For informational purposes only — not investment advice

← Back to signals

DHR

LONGINSIDER SELLCONGRESS BUY

DANAHER CORP DEL

Research: Finviz ↗·Perplexity ↗

Funds
5
Score
5.65
vs SPY
+11.9%
Stock return (since Q-end)
+16.3%
SPY return (since Q-end)
+4.5%
Current price
$221.20
Days to cover (short int.)
1.8d↑+7.5%
as of 2026-09-30

News Summary

Positive

Danaher delivered a strong Q2 beat with 60% EPS growth and raised full-year guidance, while successfully closing the $9.9B Masimo acquisition to expand AI-enabled diagnostics capabilities. However, a planned CEO transition effective October 1, 2026 and modestly lowered Q3 expectations create near-term uncertainty ahead of the October 21 earnings report.

Red flags

  • •CEO transition: Rainer Blair succeeded by Julie Sawyer Montgomery on October 1, 2026
  • •Q3 2026 guidance reset to low-single-digit growth (2-3% core revenue) versus Q2's 5.5% YoY
  • •Analyst price targets reset downward from $264.91 to $257.73 reflecting margin and growth assumption adjustments

Funds Buying (5)

FundManagerShares Held∆ SharesPosition Value% of FundQoQStatus
Glenview CapitalLarry Robbins1.1M+990K$218M4.4%+633%Existing
Third PointDan Loeb540K+15K$103M2.2%+3%Existing
Tiger GlobalChase Coleman456K+456K$87M0.4%—NEW
Duquesne Family OfficeStanley Druckenmiller50K+50K$10M0.2%—NEW
Point72Steve Cohen11K+11K$2M<0.1%—NEW

Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter. % of Fund is the position's share of the fund's reported equity portfolio — it drives the size weighting in the conviction score.

Portfolio Context

Where DHR ranks in each buying fund's book, and the positions immediately around it. What a holding sits next to often says more about the thesis than the position size does.

Glenview Capital

position #7 of this fund's book

  1. 4THERMO FISHER SCIENTIFIC INC$314M
  2. 5AMAZON COM INC$303M
  3. 6AGILENT TECHNOLOGIES INC$262M
  4. 7DANAHER CORP DEL$218M
  5. 8META PLATFORMS INC$201M
  6. 9ADVANCED MICRO DEVICES INC$173M
  7. 10TEVA PHARMACEUTICAL INDS LTD$172M
Third Point

position #19 of this fund's book

  1. 16API GROUP CORP$121M
  2. 17MASTEC INC$121M
  3. 18TRANSDIGM GROUP INC$105M
  4. 19DANAHER CORP DEL$103M
  5. 20UNION PAC CORP$95M
  6. 21TTM TECHNOLOGIES INC$94M
  7. 22PERFORMANCE FOOD GROUP CO$75M
Tiger Global

position #32 of this fund's book

  1. 29CHIME FINL INC$108M
  2. 30EQUIPMENTSHARE COM INC$90M
  3. 31SHERWIN WILLIAMS CO$89M
  4. 32DANAHER CORP DEL$87M
  5. 33SERVICENOW INC$87M
  6. 34SPACE EXPLORATION TECHN CORP$64M
  7. 35WEBULL CORP$44M

Values are quarter-end position sizes. Shown only for funds where DHR ranks inside their 40 largest equity positions — below that, neighbouring names carry no signal. Adjacency is an inference about a fund's reasoning, not a disclosure of it.

Insider Activity

NameTitleTypeSharesPriceValueFiledSrc
Blair RainerPresident & CEOSELL11K$217.77$2.46M2026-08-21↗
Blair RainerPresident & CEOSELL39K$218.73$8.57M2026-08-21↗
Blair RainerPresident & CEOSELL8K$219.35$1.70M2026-08-21↗

Beneficial Ownership (13D/13G)

FilerFormShares% of ClassFiledSrc
Vanguard Capital ManagementSC 13G47.4M6.7%2026-04-29↗

SC 13D = active intent to influence control (10-day filing deadline after crossing 5%). SC 13G = passive accumulation, no intent to influence control.

Congressional Trading

MemberChamberStateTypeAmount RangeTransaction DateFiledSrc
Alan Armstrongsenate—BUY$1,001 - $15,0002026-03-272026-07-21↗

Periodic Transaction Reports filed under the STOCK Act. Amounts are disclosed as ranges, not exact dollar figures.